1 – 5 of 5
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma : Results from the collaboration to collect autologous transplant outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT chronic malignancies working party
(
- Contribution to journal › Article
-
Mark
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
(
- Contribution to journal › Article
- 2016
-
Mark
Setting Global Standards for Stem Cell Research and Clinical Translation : The 2016 ISSCR Guidelines
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Regulation of advanced therapy medicinal products in Europe and the role of academia
(
- Contribution to journal › Scientific review
-
Mark
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
(
- Contribution to journal › Article